IN191496B - - Google Patents
Info
- Publication number
- IN191496B IN191496B IN1036DE1999A IN191496B IN 191496 B IN191496 B IN 191496B IN 1036DE1999 A IN1036DE1999 A IN 1036DE1999A IN 191496 B IN191496 B IN 191496B
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1036DE1999 IN191496B (enExample) | 1999-07-30 | 1999-07-30 | |
| BR0012865-1A BR0012865A (pt) | 1999-07-30 | 2000-07-24 | Uma forma amorfa aperfeiçoada da proxetil cefpodoxima |
| PCT/IB2000/001024 WO2001009143A1 (en) | 1999-07-30 | 2000-07-24 | An improved amorphous form of cefpodoxime proxetil |
| AU58391/00A AU5839100A (en) | 1999-07-30 | 2000-07-24 | An improved amorphous form of cefpodoxime proxetil |
| EP00944159A EP1204667A4 (en) | 1999-07-30 | 2000-07-24 | AN IMPROVED AMORPHE FORM OF CEFPODOXIM PROXETIL |
| JP2001513950A JP2003506329A (ja) | 1999-07-30 | 2000-07-24 | セフポドキシメプロキセチルの改良アモルファス形態 |
| US10/048,354 US6602999B1 (en) | 1999-07-30 | 2000-07-24 | Amorphous form of cefpodoxime proxetil |
| CN00812246A CN1371381A (zh) | 1999-07-30 | 2000-07-24 | 改进的无定形头孢泊肟酯 |
| ZA200200692A ZA200200692B (en) | 1999-07-30 | 2002-01-25 | An improved amorphous form of cefpodoxime proxetil. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1036DE1999 IN191496B (enExample) | 1999-07-30 | 1999-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN191496B true IN191496B (enExample) | 2003-12-06 |
Family
ID=11092065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1036DE1999 IN191496B (enExample) | 1999-07-30 | 1999-07-30 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6602999B1 (enExample) |
| EP (1) | EP1204667A4 (enExample) |
| JP (1) | JP2003506329A (enExample) |
| CN (1) | CN1371381A (enExample) |
| AU (1) | AU5839100A (enExample) |
| BR (1) | BR0012865A (enExample) |
| IN (1) | IN191496B (enExample) |
| WO (1) | WO2001009143A1 (enExample) |
| ZA (1) | ZA200200692B (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT408226B (de) * | 1999-05-05 | 2001-09-25 | Biochemie Gmbh | Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2 |
| WO2002068429A1 (en) * | 2001-02-27 | 2002-09-06 | Ranbaxy Laboratories Limited | Process for the preparation of cefpodoxime proxetil |
| ES2272206T1 (es) * | 2004-10-18 | 2007-05-01 | Teva Pharmaceutical Industries Ltd. | Procedimiento para la preparacion de la atorvastatina hemicalcica amorfa por disolucion de la sal en un disolvente organico que es una mezcla de un alcohol, y una cetona y/o un ester y eliminacion del disolvente. |
| WO2008010784A1 (en) * | 2005-05-16 | 2008-01-24 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising a cephalosporin |
| KR100840132B1 (ko) * | 2007-04-17 | 2008-06-23 | 재단법인서울대학교산학협력재단 | 포화 액체 이산화탄소를 사용한 세포독심 프록세틸의 건조 |
| MX2015003124A (es) * | 2012-09-11 | 2015-10-12 | Reddys Lab Ltd Dr | Formas polimorficas de enzalutamida y su preparacion. |
| US20140179749A1 (en) | 2012-09-11 | 2014-06-26 | Bend Research | Formulations of enzalutamide |
| RU2764767C2 (ru) | 2015-03-06 | 2022-01-21 | Атеа Фармасьютикалс, Инк. | β-D-2'-ДЕЗОКСИ-2'-α-ФТОР-2'-β-С-ЗАМЕЩЕННЫЕ-2-МОДИФИЦИРОВАННЫЕ-N6-ЗАМЕЩЕННЫЕ ПУРИНОВЫЕ НУКЛЕОТИДЫ ДЛЯ ЛЕЧЕНИЯ ВЫЗВАННЫХ HCV ЗАБОЛЕВАНИЙ |
| WO2017046756A1 (en) * | 2015-09-18 | 2017-03-23 | Lupin Limited | Proxetil and axetil esters of cefixime |
| MX380022B (es) * | 2016-05-09 | 2025-03-11 | Anacor Pharmaceuticals Inc | Formas cristalinas de crisaborol en forma libre, metodo de preparacion y uso de las mismas |
| US11447506B2 (en) | 2016-05-09 | 2022-09-20 | Anacor Pharmaceuticals, Inc. | Crystal forms of crisaborole in free form and preparation method and use thereof |
| CN114409665A (zh) * | 2016-06-16 | 2022-04-29 | 泽农医药公司 | 螺-吲哚酮化合物的固态形式 |
| JP2019526637A (ja) * | 2016-09-06 | 2019-09-19 | インデナ・ソチエタ・ペル・アチオニ | 固体形態のインゲノール ３−（３，５−ジエチルイソオキサゾール−４−カルボキシラート）及びその調製方法 |
| CN116036114A (zh) | 2016-09-07 | 2023-05-02 | 阿堤亚制药公司 | 用于rna病毒治疗的2’-取代的-n6-取代的嘌呤核苷酸 |
| US10336679B2 (en) * | 2016-10-24 | 2019-07-02 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| US11369579B2 (en) | 2016-10-24 | 2022-06-28 | Syneurx International (Taiwan) Corp. | Polymorphic forms of sodium benzoate and uses thereof |
| CA3048033C (en) * | 2017-02-01 | 2023-06-20 | Atea Pharmaceuticals, Inc. | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus |
| WO2018178133A1 (en) * | 2017-03-30 | 2018-10-04 | Merck Patent Gmbh | Solid form of (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)methanol |
| CN111372920B (zh) * | 2017-11-22 | 2023-10-20 | 安吉奥斯医药品有限公司 | N-(4-(4-(环丙基甲基)哌嗪-1-羰基)苯基)喹啉-8-磺酰胺的结晶形式 |
| WO2019195753A1 (en) * | 2018-04-05 | 2019-10-10 | Tolero Pharmaceuticals, Inc. | Axl kinase inhibitors and use of the same |
| EP3773753A4 (en) | 2018-04-10 | 2021-12-22 | ATEA Pharmaceuticals, Inc. | TREATMENT OF PATIENTS INFECTED WITH THE HEPATITIS C VIRUS WITH CIRRHOSIS |
| CN110251467A (zh) * | 2019-06-26 | 2019-09-20 | 北京济美堂医药研究有限公司 | 一种无定形态头孢妥仑匹酯组合物的制备方法 |
| CN110437259B (zh) * | 2019-08-14 | 2021-12-07 | 中国药科大学 | 头孢泊肟酯柚皮素共无定形物及其制备方法 |
| US20220380348A1 (en) * | 2019-10-04 | 2022-12-01 | Sumitomo Dainippon Pharma Oncology, Inc. | Axl inhibitor formulations |
| US10874687B1 (en) | 2020-02-27 | 2020-12-29 | Atea Pharmaceuticals, Inc. | Highly active compounds against COVID-19 |
| WO2022176017A1 (ja) * | 2021-02-16 | 2022-08-25 | 大塚製薬株式会社 | 非晶質体及び当該非晶質体を含む組成物 |
| IL308921A (en) | 2021-06-17 | 2024-01-01 | Atea Pharmaceuticals Inc | Combination anti-HCV therapy is beneficial |
| KR20250008762A (ko) | 2022-05-23 | 2025-01-15 | 국립대학법인 나고야공업대학 | 습식 방사법을 사용하여 무기 필러 입자를 함유하는 생분해성 섬유 재료를 연속적으로 제조하는 방법, 및 그 방법으로 제조된 코튼 형상의 뼈 재생 재료 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4223153A (en) | 1979-02-09 | 1980-09-16 | Eli Lilly And Company | Crystalline forms of N-2-(6-methoxy)benzothiazolyl N'-phenyl urea |
| IT1165253B (it) | 1979-07-12 | 1987-04-22 | Blasinachim Spa | Procedimento di fabbricazione di acido chenodesossicolico cristallino puro |
| US4486425A (en) * | 1980-09-30 | 1984-12-04 | Sankyo Company Limited | 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates |
| YU44680B (en) | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| IL100091A (en) | 1990-12-12 | 1998-08-16 | Zeneca Ltd | Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation |
| DK0531875T3 (da) * | 1991-09-07 | 2004-06-21 | Aventis Pharma Gmbh | Diastereomer af 3-cephem-4-carboxylsyre-1-(-isopropoxycarbonyloxy)-ethylester og fremgangsmåde til dens fremstilling |
| US5248699A (en) | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| AT413383B (de) * | 1998-01-09 | 2006-02-15 | Sandoz Ag | Verfahren zur isolierung eines diastereoisomerengemisches von cefpodoxim proxetil |
| KR100342943B1 (ko) * | 1999-08-04 | 2002-07-02 | 민경윤 | 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물 |
-
1999
- 1999-07-30 IN IN1036DE1999 patent/IN191496B/en unknown
-
2000
- 2000-07-24 AU AU58391/00A patent/AU5839100A/en not_active Abandoned
- 2000-07-24 JP JP2001513950A patent/JP2003506329A/ja active Pending
- 2000-07-24 EP EP00944159A patent/EP1204667A4/en not_active Withdrawn
- 2000-07-24 US US10/048,354 patent/US6602999B1/en not_active Expired - Fee Related
- 2000-07-24 CN CN00812246A patent/CN1371381A/zh active Pending
- 2000-07-24 WO PCT/IB2000/001024 patent/WO2001009143A1/en not_active Ceased
- 2000-07-24 BR BR0012865-1A patent/BR0012865A/pt not_active Application Discontinuation
-
2002
- 2002-01-25 ZA ZA200200692A patent/ZA200200692B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0012865A (pt) | 2002-07-09 |
| ZA200200692B (en) | 2003-05-28 |
| AU5839100A (en) | 2001-02-19 |
| JP2003506329A (ja) | 2003-02-18 |
| WO2001009143A1 (en) | 2001-02-08 |
| EP1204667A1 (en) | 2002-05-15 |
| CN1371381A (zh) | 2002-09-25 |
| EP1204667A4 (en) | 2002-10-30 |
| US6602999B1 (en) | 2003-08-05 |